Steven I. Shedlofsky, MD

Clinical interests

  • Drug-Induced Liver Disease
  • Gastroenterology
  • Hepatitis C
  • Iron Overload
  • Iron Storage Disease
  • Liver Transplantation
  • Porphyrias

Steven I. Shedlofsky, MD

Biography

My name is Steven Shedlofsky; I received my medical degree from the University of Michigan Medical School, Ann Arbor. I then completed a fellowship at Washington University Barnes-Jewish Medical Center, St. Louis.

I am board certified by the American Board of Internal Medicine in Gastroenterology and Transplant Hepatology.

Faculty rank

Professor of Medicine and Toxicology

Education

Degree
University of Michigan Medical School, Ann Arbor

Residency
University of Pennsylvania Hospital, Philadelphia

Fellowship
Washington University Barnes-Jewish Medical Center, St. Louis

Certifications or Special training
American Board of Internal Medicine
American Board of Internal Medicine, Gastroenterology
American Board of Internal Medicine, Transplant Hepatology 

Digestive Diseases & Nutrition

Kentucky Clinic
Second Floor, Wing C
740 S. Limestone
Lexington KY 40536-0284

Call 859-323-0079
Fax 859-257-9501

Amenities
Dining, Internet/Wi-Fi, Information desk, Pharmacy services, Wheelchairs

Kentucky Clinic Map (PDF, 616 KB) »
Directions to Kentucky Clinic Parking »


UK HealthCare accepts many forms of insurance. See list of insurers »

 

Recent Publications

(Five most recent publications from PubMed via an automated list based on the provider’s ID and the University of Kentucky.)
  1. Deaciuc IV, Peng X, D'Souza NB, Shedlofsky SI, Burikhanov R, Voskresensky IV, de Villiers WJ.
    Microarray gene analysis of the liver in a rat model of chronic, voluntary alcohol intake.
    Alcohol. 2004 Feb;32(2):113-27.
  2. Shedlofsky SI, Tosheva RT, Snawder JA.
    Depression of constitutive murine cytochromes P450 by staphylococcal enterotoxin B.
    Biochem Pharmacol. 2000 May 15;59(10):1295-303.
  3. Poloyac SM, Tosheva RT, Gardner BM, Shedlofsky SI, Blouin RA.
    The effect of endotoxin administration on the pharmacokinetics of chlorzoxazone in humans.
    Clin Pharmacol Ther. 1999 Dec;66(6):554-62.
  4. Watson AM, Warren G, Howard G, Shedlofsky SI, Blouin RA.
    Activities of conjugating and antioxidant enzymes following endotoxin exposure.
    J Biochem Mol Toxicol. 1999;13(2):63-9.
  5. Roe AL, Warren G, Hou G, Howard G, Shedlofsky SI, Blouin RA.
    The effect of high dose endotoxin on CYP3A2 expression in the rat.
    Pharm Res. 1998 Oct;15(10):1603-8.

View this provider on PubMed